The Glimpse Group Reports Q2 Fiscal Year 2025 Financial Results - 50% Increase in Revenue and Positive EBITDA, Positive Cash Flow & Positive Net Income
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR)(FSE:9DR), a diversified Immersive Technology platform company providing enterprise-focused Virtual Reality ("VR"), Augmented Reality ("AR") and Spatial Computing software and services, provided financial results for its second quarter fiscal year 2025 year, ended December 31, 2024 ("Q2 FY '25").
Business Commentary by President & CEO Lyron Bentovim
Financial Summary:
Q2 FY '25 revenue of approximately $3.17 million, reflecting: a) 52% increase compared to Q2 FY '24 (ending December 31, 2023) revenue of approximately $2.08 million, and b) 30% increase compared to Q1 FY '25 (ending September 30, 2024) revenue of approximately $2.44 million. The increase in both comparative periods was primarily driven by an increase in Spatial Core revenues, as well as growth in our other businesses.
Gross Margin for Q2 FY ‘25 was approximately 64% compared to 68% for Q2 FY ‘24. The decrease was driven by revenue mix which tends to oscillate a bit between quarters. On average, we expect our going forward Gross Margin to continue to be in the 60-70% range.
Q2 FY '25 positive adjusted EBITDA of approximately $0.28 million, compared to an adjusted EBITDA loss of approximately -$1.33 million for Q2 FY '24. Net Operating Cash provided from Operations for Q2 FY '25 was approximately $0.17 million, compared to a Net Operating Cash loss of approximately -$1.68 million for Q2 FY '24. Importantly, this is the first profitable EBITDA quarter in the Company's history as a publicly traded company, reflecting our significant restructuring efforts over the past few quarters combined with revenue growth.
Driven by the timing of existing contracts revenue recognition, for Q3 FY '25 we expect a decline in revenue ($1.5-2 million) and negative adjusted EBITDA, to be more than offset by a strong Q4 FY '25 ($3.3-4.0 million revenue) and positive adjusted EBITDA. For FY '25 (ending June 30, 2025), we expect aggregate revenue to exceed $11 million, compared to $8.8 million for FY '24 (ended June 30, 2024), a 25%+ increase in annual revenue and breakeven adjusted EBITDA for the fiscal year vs. a significant adjusted EBITDA loss in the prior fiscal year.
The Company's cash and equivalent position as of December 31, 2024 was approximately $8.5 million, with an additional $1.4 million in accounts receivable. The increase in our cash position was primarily a result of our December 2024 registered direct equity financing, in which we raised $7.3 million in gross cash proceeds from one investor in a clean structure. We continue to maintain a clean capital structure with no debt, no convertible debt and no preferred equity.
On December 24, 2024, we received written notice from the Nasdaq informing the Company that it had regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. This closes the matter that originated on September 3, 2024.
For the full detail of our financial results, please refer to our 8K and 10Q filed on 2/13/25.
Recent Business Updates:
During the quarter, Brightline Interactive ("BLI") delivered a significant milestone on its $4 million+ Department of Defense ("DoD") contract.
BLI entered into an initial contract with the US Navy for an Immersive, AI-Driven Simulator System, to be delivered in the coming months, setting the ground for potential follow-on contracts.
BLI delivered a scalable immersive simulation to a global government service integrator, positioning itself as a leading middleware for processing and visualizing complex information in 3D space, and setting what we believe has the potential to become a new industry standard.
The Continuing Resolution and the lack of a Federal budget for 2025 has delayed the potential awarding of multiple Government and DoD opportunities. We hope this will be resolved promptly in March 2025 when the current Continuing Resolution expires and with a new administration and Congress now in place.
Led by Foretell Reality, we continue to make strong progress on commercializing our AI driven immersive training product and have experienced encouraging initial traction with our customers and partners.
Q2 Fiscal Year 2025 Conference Call and Webcast
Date: Thursday, February 13, 2025
Time: 9:00 a.m. Eastern time
USA Dial In: 888-506-0062
International: +1-973-528-0011
Participant Access Code: 831836
Webcast: https://www.webcaster4.com/Webcast/Page/2934/52015
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A playback of the webcast will be available through Friday, February 13, 2026. A replay of the teleconference will be available through February 27, 2025. To listen, please call USA: 877-481-4010 or International: +1-919-882-2331; Replay Passcode: 52015. A webcast will also be available on the IR section of The Glimpse Group website (ir.theglimpsegroup.com) or by clicking the webcast link above.
Note about Non-GAAP Financial Measures
A non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with accounting principles generally accepted in the United States of America, or GAAP. Non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Other companies may use different non-GAAP measures and presentation of results.
In addition to financial results presented in accordance with GAAP, this press release presents adjusted EBITDA, which is a non-GAAP measure. Adjusted EBITDA is determined by taking net loss and adding interest, taxes, depreciation, amortization and stock-based compensation expenses. The company believes that this non-GAAP measure, viewed in addition to and not in lieu of net loss, provides useful information to investors by providing a more focused measure of operating results. This metric is an integral part of the Company's internal reporting to evaluate its operations and the performance of senior management. A reconciliation of adjusted EBITDA to net loss, the most comparable GAAP measure, is available in the accompanying financial tables below. The non-GAAP measure presented herein may not be comparable to similarly titled measures presented by other companies.
About The Glimpse Group, Inc.
The Glimpse Group (NASDAQ: VRAR) is a diversified Immersive technology platform company, providing enterprise-focused Virtual Reality, Augmented Reality and Spatial Computing software & services. Glimpse's unique business model builds scale and a robust ecosystem, while simultaneously providing investors an opportunity to invest directly into this emerging industry via a diversified platform. For more information on The Glimpse Group, please visit www.theglimpsegroup.com
Safe Harbor Statement
This press release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. This press release may contain certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements, if provided, are based on information available to the Company as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business. Forward-looking statements, if provided, include statements regarding our expectations, beliefs, intentions, or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "view," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. All forecasts, if provided, are based on information available at this time and management expects that internal projections and expectations may change over time. In addition, any forecasts, if provided, are entirely on management's best estimate of our future financial performance given our current contracts, current backlog of opportunities and conversations with new and existing customers about our products and services. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise.
Company Contact:
Maydan Rothblum
CFO & COO
The Glimpse Group, Inc.
(917) 292-2685
maydan@theglimpsegroup.com
THE GLIMPSE GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
|
| As of |
|
| As of |
| ||
|
| (Unaudited) |
|
| (Audited) |
| ||
| ASSETS |
|
|
|
|
|
| ||
| Cash and cash equivalents |
| $ | 8,445,288 |
|
| $ | 1,848,295 |
|
| Accounts receivable |
|
| 1,391,879 |
|
|
| 723,032 |
|
| Deferred costs/contract assets |
|
| 222,784 |
|
|
| 170,781 |
|
| Notes receivable |
|
| 124,900 |
|
|
| - |
|
| Prepaid expenses and other current assets |
|
| 678,424 |
|
|
| 778,181 |
|
| Total current assets |
|
| 10,863,275 |
|
|
| 3,520,289 |
|
|
|
|
|
|
|
|
| |
| Equipment and leasehold improvements, net |
|
| 73,244 |
|
|
| 167,325 |
|
| Right-of-use assets, net |
|
| 187,688 |
|
|
| 452,808 |
|
| Intangible assets, net |
|
| 261,789 |
|
|
| 487,867 |
|
| Goodwill |
|
| 10,857,600 |
|
|
| 10,857,600 |
|
| Other assets |
|
| 11,100 |
|
|
| 72,714 |
|
| Total assets |
| $ | 22,254,696 |
|
| $ | 15,558,603 |
|
|
|
|
|
|
|
|
| |
| LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
| Accounts payable |
| $ | 295,776 |
|
| $ | 181,668 |
|
| Accrued liabilities |
|
| 633,355 |
|
|
| 340,979 |
|
| Deferred revenue/contract liabilities |
|
| 263,347 |
|
|
| 72,788 |
|
| Lease liabilities, current portion |
|
| 143,929 |
|
|
| 364,688 |
|
| Contingent consideration for acquisitions, current portion |
|
| 2,942,651 |
|
|
| 1,467,475 |
|
| Total current liabilities |
|
| 4,279,058 |
|
|
| 2,427,598 |
|
|
|
|
|
|
|
|
| |
| Long term liabilities |
|
|
|
|
|
|
|
|
| Contingent consideration for acquisitions, net of current portion |
|
| - |
|
|
| 1,413,696 |
|
| Lease liabilities, net of current portion |
|
| 57,690 |
|
|
| 178,824 |
|
| Total liabilities |
|
| 4,336,748 |
|
|
| 4,020,118 |
|
| Commitments and contingencies |
|
| - |
|
|
| - |
|
| Stockholders' Equity |
|
|
|
|
|
|
|
|
| Preferred Stock, par value $0.001 per share, 20 million shares authorized; 0 shares issued and outstanding |
|
| - |
|
|
| - |
|
| Common Stock, par value $0.001 per share, 300 million shares authorized; 20,272,006 and 18,158,217 issued and outstanding, respectively |
|
| 20,272 |
|
|
| 18,158 |
|
| Additional paid-in capital |
|
| 81,925,269 |
|
|
| 74,559,600 |
|
| Accumulated deficit |
|
| (64,027,593 | ) |
|
| (63,039,273 | ) |
| Total stockholders' equity |
|
| 17,917,948 |
|
|
| 11,538,485 |
|
| Total liabilities and stockholders' equity |
| $ | 22,254,696 |
|
| $ | 15,558,603 |
|
THE GLIMPSE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
| For the Three Months Ended |
|
| For the Six Months Ended |
| ||||||||||
|
| December 31 |
|
| December 31 |
| ||||||||||
|
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
| ||||
| Revenue |
|
|
|
|
|
|
|
|
|
|
|
| ||||
| Software services |
| $ | 3,129,108 |
|
| $ | 2,032,272 |
|
| $ | 5,358,365 |
|
| $ | 5,044,343 |
|
| Software license/software as a service |
|
| 39,826 |
|
|
| 44,153 |
|
|
| 248,938 |
|
|
| 136,962 |
|
| Total Revenue |
|
| 3,168,934 |
|
|
| 2,076,425 |
|
|
| 5,607,303 |
|
|
| 5,181,305 |
|
| Cost of goods sold |
|
| 1,144,007 |
|
|
| 655,509 |
|
|
| 1,659,310 |
|
|
| 1,837,018 |
|
| Gross Profit |
|
| 2,024,927 |
|
|
| 1,420,916 |
|
|
| 3,947,993 |
|
|
| 3,344,287 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development expenses |
|
| 659,699 |
|
|
| 1,391,883 |
|
|
| 1,780,222 |
|
|
| 3,072,670 |
|
| General and administrative expenses |
|
| 845,381 |
|
|
| 1,045,085 |
|
|
| 1,782,660 |
|
|
| 2,141,236 |
|
| Sales and marketing expenses |
|
| 384,223 |
|
|
| 765,116 |
|
|
| 1,123,098 |
|
|
| 1,578,858 |
|
| Amortization of acquisition intangible assets |
|
| 100,536 |
|
|
| 291,036 |
|
|
| 226,077 |
|
|
| 659,156 |
|
| Goodwill impairment |
|
| - |
|
|
| - |
|
|
| - |
|
|
| 379,038 |
|
| Intangible asset impairment |
|
| - |
|
|
| 8,275 |
|
|
| - |
|
|
| 522,166 |
|
| Change in fair value of acquisition contingent consideration |
|
| 28,161 |
|
|
| (1,268,014 | ) |
|
| 61,480 |
|
|
| (4,025,544 | ) |
| Total operating expenses |
|
| 2,018,000 |
|
|
| 2,233,381 |
|
|
| 4,973,537 |
|
|
| 4,327,580 |
|
| Income (loss) from operations before other income |
|
| 6,927 |
|
|
| (812,465 | ) |
|
| (1,025,544 | ) |
|
| (983,293 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Other income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest income |
|
| 18,945 |
|
|
| 74,098 |
|
|
| 37,224 |
|
|
| 125,483 |
|
| Net Income (loss) |
| $ | 25,872 |
|
| $ | (738,367 | ) |
| $ | (988,320 | ) |
| $ | (857,810 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Basic net income (loss) per share |
| $ | 0.00 |
|
| $ | (0.04 | ) |
| $ | (0.05 | ) |
| $ | (0.05 | ) |
| Diluted net income (loss) per share |
| $ | 0.00 |
|
| $ | (0.04 | ) |
| $ | (0.05 | ) |
| $ | (0.05 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Weighted-average shares used to compute basic net income (loss) per share |
|
| 18,361,274 |
|
|
| 16,668,740 |
|
|
| 18,262,745 |
|
|
| 15,699,563 |
|
| Weighted-average shares used to compute diluted net income (loss) per share |
|
| 24,521,976 |
|
|
| 16,668,740 |
|
|
| 18,262,745 |
|
|
| 15,699,563 |
|
THE GLIMPSE GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
|
| For the Six Months Ended December 31, |
| |||||
|
| 2024 |
|
| 2023 |
| ||
| Cash flows from operating activities: |
|
|
|
|
|
| ||
| Net loss |
| $ | (988,320 | ) |
| $ | (857,810 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
| Amortization and depreciation |
|
| 272,615 |
|
|
| 720,458 |
|
| Common stock and stock option based compensation for employees and board of directors |
|
| 407,231 |
|
|
| 1,135,048 |
|
| Net gain on divestiture of subsidiaries |
|
| (1,397,066 | ) |
|
| (1,000,000 | ) |
| Reserve on note received in connection with divestiture of subsidiaries |
|
| 1,500,000 |
|
|
| 1,000,000 |
|
| Gain on office lease termination |
|
| (34,660 | ) |
|
| - |
|
| Accrued non cash performance bonus fair value adjustment |
|
| - |
|
|
| (551,234 | ) |
| Acquisition contingent consideration fair value adjustment |
|
| 61,480 |
|
|
| (4,025,544 | ) |
| Impairment of intangible assets |
|
| - |
|
|
| 901,204 |
|
| Issuance of common stock to vendors |
|
| - |
|
|
| 73,282 |
|
| Adjustment to operating lease right-of-use assets and liabilities |
|
| (41,787 | ) |
|
| (89,376 | ) |
|
|
|
|
|
|
|
| |
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
| Accounts receivable |
|
| (668,847 | ) |
|
| 208,052 |
|
| Deferred costs/contract assets |
|
| (52,003 | ) |
|
| 81,560 |
|
| Loans receivable |
|
| (40,900 | ) |
|
| - |
|
| Prepaid expenses and other current assets |
|
| 99,757 |
|
|
| (99,231 | ) |
| Other assets |
|
| 5,349 |
|
|
| (1,507 | ) |
| Accounts payable |
|
| 114,108 |
|
|
| (180,077 | ) |
| Accrued liabilities |
|
| 295,521 |
|
|
| (343,474 | ) |
| Deferred revenue/contract liabilities |
|
| 214,369 |
|
|
| (329,531 | ) |
| Net cash used in operating activities |
|
| (253,153 | ) |
|
| (3,358,180 | ) |
| Cash flow from investing activities: |
|
|
|
|
|
|
|
|
| Purchase of leasehold improvements and equipment |
|
| (26,406 | ) |
|
| (8,751 | ) |
| Net cash used in investing activities |
|
| (26,406 | ) |
|
| (8,751 | ) |
| Cash flows provided by financing activities: |
|
|
|
|
|
|
|
|
| Proceeds from securities purchase agreement, net |
|
| 6,785,552 |
|
|
| 2,968,501 |
|
| Proceeds from exercise of warrants |
|
| 175,000 |
|
|
| - |
|
| Issuance of note receivable |
|
| (84,000 | ) |
|
| - |
|
| Cash provided by financing activities |
|
| 6,876,552 |
|
|
| 2,968,501 |
|
|
|
|
|
|
|
|
| |
| Net change in cash and cash equivalents |
|
| 6,596,993 |
|
|
| (398,430 | ) |
| Cash and cash equivalents, beginning of year |
|
| 1,848,295 |
|
|
| 5,619,083 |
|
| Cash and cash equivalents, end of period |
| $ | 8,445,288 |
|
| $ | 5,220,653 |
|
|
|
|
|
|
|
|
| |
| Non-cash Investing and Financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Issuance of common stock for satisfaction of contingent liability |
| $ | - |
|
| $ | 127,145 |
|
| Issuance of common stock for non cash performance bonus |
| $ | - |
|
| $ | 127,145 |
|
| Lease liabilities arising from right-of-use assets |
| $ | 20,344 |
|
| $ | 113,182 |
|
The following table presents a reconciliation of net loss to Adjusted EBITDA for the three and six months ended December 31, 2024 and 2023:
|
| For the Three Months Ended |
|
| For the Six Months Ended |
| ||||||||||
|
| December 31, |
|
| December 31, |
| ||||||||||
|
| 2024 |
|
| 2023 |
|
| 2024 |
|
| 2023 |
| ||||
|
| (in millions) |
|
| (in millions) |
| ||||||||||
| Net income (loss ) |
| $ | 0.02 |
|
| $ | (0.74 | ) |
| $ | (0.98 | ) |
| $ | (0.86 | ) |
| Depreciation and amortization |
|
| 0.12 |
|
|
| 0.32 |
|
|
| 0.27 |
|
|
| 0.72 |
|
| EBITDA income (loss) |
|
| 0.14 |
|
|
| (0.42 | ) |
|
| (0.71 | ) |
|
| (0.14 | ) |
| Stock based compensation expenses |
|
| 0.04 |
|
|
| 0.51 |
|
|
| 0.41 |
|
|
| 1.21 |
|
| Loss on subsidiary divestiture |
|
| 0.10 |
|
|
| - |
|
|
| 0.10 |
|
|
| - |
|
| Gain on office lease termination |
|
| (0.03 | ) |
|
| - |
|
|
| (0.03 | ) |
|
| - |
|
| Intangible asset impairment |
|
| - |
|
|
| 0.01 |
|
|
| - |
|
|
| 0.90 |
|
| Non cash change in fair value of accrued performance bonus |
|
| - |
|
|
| (0.16 | ) |
|
| 0.06 |
|
|
| (0.55 | ) |
| Non cash change in fair value of acquisition contingent consideration |
|
| 0.03 |
|
|
| (1.27 | ) |
|
| - |
|
|
| (4.03 | ) |
Adjusted EBITDA income (loss) |
| $ | 0.28 |
|
| $ | (1.33 | ) |
| $ | (0.17 | ) |
| $ | (2.61 | ) |
SOURCE: The Glimpse Group, Inc.
View the original press release on ACCESS Newswire
The Glimpse Group, Inc.

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom